Copyright
©The Author(s) 2022.
World J Clin Cases. Aug 6, 2022; 10(22): 7950-7959
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7950
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7950
Table 1 Review of the literature on primary spinal cord glioblastoma with qualified magnetic resonance images
Case No. | Ref. | Age/sex | Symptoms | Lesion location | Intramedullary only | Imaging findings | Surgery/therapy | Survival in month |
1 | Ferrante et al[3], 2021 | 34 yr/F | MW, SD | Nearly entire cervical spinal cord and medulla oblongata | Yes | Isointense to hypointense on T1WI, isointense to hyperintense on T2WI, homogeneous enhancement | None | NR |
64 yr/M | MW, SD | Conus medullaris | Yes | Hyperintense on T2WI, peripheral enhancement, necrosis enhancing nodule | STR, radio/chemotherapy | 33 | ||
47 yr/M | Paresthesia, pain, MW, SD | Cervical and thoracic | Yes | Multifocal lesion (C5-C7) and (T3-T5), peripheral enhancement, necrotic center | Biopsy, radio/chemotherapy | 10 | ||
2 | Shen et al[4], 2020 | 47 yr/F | Paresthesia, paralysis | T12 | Yes | T12 nodular, isointense to hyperintense on T2WI, central significant enhancement | surgical resection, NR | NR |
3 | Delgado et al[5], 2019 | 21 yr/F | Pain, weakness, paresthesia | T10-T12, L1 | Yes | 60 mm expansile mass, T10-T12 down to L1, nodular significant enhancement | NTR, radio/chemotherapy | Recurrence in 4 mo |
4 | Chanchotisatien et al[6], 2019 | 27 yr/F | Dysuria, numbness, weakness, back Pain | T4-T12, T5-T12, respectively | No | Homogenous, hyperintense T2WI, intra-/extramedullary regions from T4-T12 and T5-T12, respectively, homogenous enhancement | Biopsy, radio/chemotherapy | NR |
5 | Caro-Osorio et al[7], 2018 | 48 yr/F | Numbness, pain | C1-C3 | Yes | Hypointense on T1WI, hyperintense on T2WI, heterogeneous enhancement | STR, radio/chemotherapy | 8 |
6 | Shen et al[1], 2017 | 15 yr/F | Numbness, weakness | C4-C7 | Yes | Hyperintense on T2WI, inhomogeneous enhancement | NTR, radio/chemotherapy | 13 |
7 | Nunn et al[12], 2017 | 31 yr/M | MW, SD | T9-T2 | Yes | Hyperintense on T2WI, spinal cord expanding, heterogeneous enhancement | Surgical resection, radio/chemotherapy | 14 |
8 | Prasad et al[13], 2012 | 15 yr/F | Paraparesis, dysesthesia, urinary incontinence, SD | C6-T7 | Yes | Enlargement of cord, heterogeneously enhancing | STR, radio/chemotherapy | 6 |
35 yr/M | Pain, paraplegia, urinary incontinence, SD | T11-L1 | Yes | Enlargement of cord, heterogeneously enhancing | NTR, radio/chemotherapy | 15 |
- Citation: Liang XY, Chen YP, Li Q, Zhou ZW. Atypical imaging features of the primary spinal cord glioblastoma: A case report. World J Clin Cases 2022; 10(22): 7950-7959
- URL: https://www.wjgnet.com/2307-8960/full/v10/i22/7950.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i22.7950